Franklin Resources Inc. Makes New Investment in Omada Health, Inc. $OMDA
Franklin Resources Inc. acquired 147,251 shares of Omada Health, Inc., valued at $2,695,000, during Q2. Analysts have given Omada Health a "Moderate Buy" rating, with price targets ranging from $26 to $29. Despite this, the stock is trading down 12.6% at $16.13. Several other institutional investors also purchased stakes in Omada Health during the same period.
Franklin Resources Inc. bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 147,251 shares of the company's stock, valued at approximately $2,695,000. Franklin Resources Inc. owned approximately 0.57% of Omada Health at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the business. Geode Capital Management LLC purchased a new position in Omada Health during the 2nd quarter valued at about $637,000. Teacher Retirement System of Texas purchased a new position in shares of Omada Health during the second quarter valued at approximately $640,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $2,950,000. Jennison Associates LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $4,580,000. Finally, Emerald Advisers LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $5,089,000.
Wall Street Analysts Forecast Growth
Several research firms have commented on OMDA. Needham & Company LLC boosted their target price on Omada Health from $26.00 to $28.00 and gave the stock a "buy" rating in a report on Friday, November 7th. Barclays upped their price target on shares of Omada Health from $28.00 to $29.00 and gave the stock an "overweight" rating in a research note on Friday, November 7th. Evercore ISI raised their price objective on shares of Omada Health from $27.00 to $28.00 and gave the company an "outperform" rating in a research note on Friday, November 7th. Canaccord Genuity Group upped their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Baird R W upgraded shares of Omada Health to a "hold" rating in a report on Friday, September 5th. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $26.33.
Check Out Our Latest Stock Analysis on Omada Health
Omada Health Trading Down 12.6%
OMDA opened at $16.13 on Thursday. The company's 50-day moving average is $22.24. Omada Health, Inc. has a 52-week low of $14.14 and a 52-week high of $28.40.
Omada Health Profile
(Free Report)Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.
Featured Articles
- Five stocks we like better than Omada Health
- What is a Death Cross in Stocks?
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- What is the Shanghai Stock Exchange Composite Index?
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stocks You’ll Wish You Bought Before 2026
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Omada Health Right Now?
Before you consider Omada Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.
While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
